Incidence of biomarker positivity cancer patients 2017 U.S. by type

Published by
Matej Mikulic,
Jan 22, 2020
This statistic shows the Percentage of U.S. patients with selected cancer types with positivity for newly available biomarkers (after 2006), as of 2017. Among patients with BRAF mut melanoma, 50 percent tested positive for newly available biomarkers.

Percentage of U.S. patients with selected cancer types with positivity for newly available biomarkers as of 2017*

Loading statistic...

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

May 2018

Region

Worldwide

Survey time period

as of 2017

Supplementary notes

* Biomarkers newly available post-2006

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$229 USD $199 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Personalized medicine "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Personalized medicine

Premises

7

Biomarkers

6

PM key data

5

Views on PM

6

Outlook

4

Further related statistics

16

Further Content: You might find this interesting as well

Statistics

Topics

Personalized medicineGlobal pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsCancer in the U.S.
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu